Alx Oncology Holdings Eigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 1.945 USD | 2,66 USD | 0,51 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 4,6 USD | 3 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 134.562.917 | 6,17 | 3,57 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Alx Oncology Holdings
Mitarbeiter 43
Handelsplatz NASDAQ
Ticker Symbol ALXO
IPO Datum 2020-07-17
Adresse 323 Allerton Avenue, South San Francisco, CA, United States, 94080
Webseite https://www.alxoncology.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Jason W. Lettmann | CEO & Director |
| 2 | Mr. Harish Shantharam C.F.A. | Chief Financial Officer |
| 3 | Ms. Shelly Wong CPA | Senior VP of Finance & Chief Accounting Officer |
| 4 | Dr. Barbara J. Klencke M.D. | Chief Medical Officer |
| 5 | Mr. Jeff E. Knight M.P.H. | Chief Development & Operating Officer |
| 6 | Mr. Michael Listgarten | General Counsel |
| 7 | Dr. Athanasios Tsiatis M.D. | Senior Vice President of Clinical Development |
| 8 | Dr. Lin Yeong-Liang M.D., M.S. | Senior Vice President of Drug Safety & Pharmacovigilance |
| 9 | Ms. Lisa Sauer | Senior Vice President of Regulatory Affairs & Quality Assurance |
| 10 | Ms. Sue Naim | Senior Vice President of Clinical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 2 | TCG Crossover Management, LLC | 0,00% | 0,00 Mio. USD |
| 3 | venBio Partners LLC | 0,00% | 0,00 Mio. USD |
| 4 | Redmile Group, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Blackstone Inc | 0,00% | 0,00 Mio. USD |
| 6 | Driehaus Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Marshall Wace Asset Management Ltd | 0,00% | 0,00 Mio. USD |
| 9 | Vivo Capital, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Almitas Capital LLC | 0,00% | 0,00 Mio. USD |
| 11 | 5AM Venture Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Orbimed Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 14 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 15 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 16 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 17 | Squadron Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 18 | Susquehanna International Group, LLP | 0,00% | 0,00 Mio. USD |
| 19 | Acadian Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 20 | Ensign Peak Advisors Inc | 0,00% | 0,00 Mio. USD |